C.M. Bidwell & Associates’s BioMarin Pharmaceuticals BMRN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2017
Q2
Sell
-3,505
Closed -$308K 327
2017
Q1
$308K Buy
+3,505
New +$308K 0.07% 121